Sex disparities in cancer mortality: the risks of being a man in the United States.

Bobby B Najari; Michael Rink; Philip S Li; Pierre I Karakiewicz; Douglas S Scherr; Ridwan Shabsigh; Siegfried Meryn; Peter N Schlegel; Shahrokh F Shariat

doi:10.1016/j.juro.2012.11.153

Sex disparities in cancer mortality: the risks of being a man in the United States.

Standard

Sex disparities in cancer mortality: the risks of being a man in the United States. / Najari, Bobby B; Rink, Michael; Li, Philip S; Karakiewicz, Pierre I; Scherr, Douglas S; Shabsigh, Ridwan; Meryn, Siegfried; Schlegel, Peter N; Shariat, Shahrokh F.

in: J UROLOGY, Jahrgang 189, Nr. 4, 4, 2013, S. 1470-1474.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Najari, BB, Rink, M, Li, PS, Karakiewicz, PI, Scherr, DS, Shabsigh, R, Meryn, S, Schlegel, PN & Shariat, SF 2013, 'Sex disparities in cancer mortality: the risks of being a man in the United States.', J UROLOGY, Jg. 189, Nr. 4, 4, S. 1470-1474. https://doi.org/10.1016/j.juro.2012.11.153

APA

Najari, B. B., Rink, M., Li, P. S., Karakiewicz, P. I., Scherr, D. S., Shabsigh, R., Meryn, S., Schlegel, P. N., & Shariat, S. F. (2013). Sex disparities in cancer mortality: the risks of being a man in the United States. J UROLOGY, 189(4), 1470-1474. [4]. https://doi.org/10.1016/j.juro.2012.11.153

Vancouver

Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R et al. Sex disparities in cancer mortality: the risks of being a man in the United States. J UROLOGY. 2013;189(4):1470-1474. 4. https://doi.org/10.1016/j.juro.2012.11.153

Bibtex

@article{cd9fce2dae6349f093dd64c73b620e17,

title = "Sex disparities in cancer mortality: the risks of being a man in the United States.",

abstract = "PURPOSE: In the United States more men are diagnosed with cancer than women. We quantified the differential mortality rates of nonsex specific cancers between the sexes and compared cancer stage distributions.MATERIALS AND METHODS: In this descriptive epidemiological study we obtained the incidence of new cancer cases, cancer deaths and stage distributions for the last 10 years in the United States from SEER (Surveillance, Epidemiology and End Results) program results. Sex specific cancers were excluded from study. We compared male-to-female relative mortality rate for all cancers as well as the average male-to-female relative mortality rate weighted by cancer incidence in the last 10 years. Sex specific stage distributions were also compared with the Kendall τ-c test.RESULTS: The male-to-female relative mortality rate for any cancer was 1.060 (95% CI 1.055-1.065). The average male-to-female relative mortality rate for the same cancer was 1.126 (95% CI 1.086-1.168). The discrepancy in incidence and mortality rates was stable for the last 10 years. Of the top 10 most common cancers men had an unfavorable stage distribution in all except colorectal, bladder and brain cancers.CONCLUSIONS: Men are more likely to have nonsex specific cancer than women and more likely to die of the cancer even after controlling for the incidence. This discrepancy has been stable for the last decade. For 7 of the 10 most commonly occurring nonsex specific cancers, representing 78% of all incident cancers, men are more likely to be diagnosed with advanced stage.",

keywords = "Humans, Male, Female, Risk Factors, Sex Distribution, United States/epidemiology, Neoplasms/*mortality, Humans, Male, Female, Risk Factors, Sex Distribution, United States/epidemiology, Neoplasms/*mortality",

author = "Najari, {Bobby B} and Michael Rink and Li, {Philip S} and Karakiewicz, {Pierre I} and Scherr, {Douglas S} and Ridwan Shabsigh and Siegfried Meryn and Schlegel, {Peter N} and Shariat, {Shahrokh F}",

year = "2013",

doi = "10.1016/j.juro.2012.11.153",

language = "English",

volume = "189",

pages = "1470--1474",

journal = "J UROLOGY",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "4",

}

RIS

TY - JOUR

T1 - Sex disparities in cancer mortality: the risks of being a man in the United States.

AU - Najari, Bobby B

AU - Rink, Michael

AU - Li, Philip S

AU - Karakiewicz, Pierre I

AU - Scherr, Douglas S

AU - Shabsigh, Ridwan

AU - Meryn, Siegfried

AU - Schlegel, Peter N

AU - Shariat, Shahrokh F

PY - 2013

Y1 - 2013

N2 - PURPOSE: In the United States more men are diagnosed with cancer than women. We quantified the differential mortality rates of nonsex specific cancers between the sexes and compared cancer stage distributions.MATERIALS AND METHODS: In this descriptive epidemiological study we obtained the incidence of new cancer cases, cancer deaths and stage distributions for the last 10 years in the United States from SEER (Surveillance, Epidemiology and End Results) program results. Sex specific cancers were excluded from study. We compared male-to-female relative mortality rate for all cancers as well as the average male-to-female relative mortality rate weighted by cancer incidence in the last 10 years. Sex specific stage distributions were also compared with the Kendall τ-c test.RESULTS: The male-to-female relative mortality rate for any cancer was 1.060 (95% CI 1.055-1.065). The average male-to-female relative mortality rate for the same cancer was 1.126 (95% CI 1.086-1.168). The discrepancy in incidence and mortality rates was stable for the last 10 years. Of the top 10 most common cancers men had an unfavorable stage distribution in all except colorectal, bladder and brain cancers.CONCLUSIONS: Men are more likely to have nonsex specific cancer than women and more likely to die of the cancer even after controlling for the incidence. This discrepancy has been stable for the last decade. For 7 of the 10 most commonly occurring nonsex specific cancers, representing 78% of all incident cancers, men are more likely to be diagnosed with advanced stage.

AB - PURPOSE: In the United States more men are diagnosed with cancer than women. We quantified the differential mortality rates of nonsex specific cancers between the sexes and compared cancer stage distributions.MATERIALS AND METHODS: In this descriptive epidemiological study we obtained the incidence of new cancer cases, cancer deaths and stage distributions for the last 10 years in the United States from SEER (Surveillance, Epidemiology and End Results) program results. Sex specific cancers were excluded from study. We compared male-to-female relative mortality rate for all cancers as well as the average male-to-female relative mortality rate weighted by cancer incidence in the last 10 years. Sex specific stage distributions were also compared with the Kendall τ-c test.RESULTS: The male-to-female relative mortality rate for any cancer was 1.060 (95% CI 1.055-1.065). The average male-to-female relative mortality rate for the same cancer was 1.126 (95% CI 1.086-1.168). The discrepancy in incidence and mortality rates was stable for the last 10 years. Of the top 10 most common cancers men had an unfavorable stage distribution in all except colorectal, bladder and brain cancers.CONCLUSIONS: Men are more likely to have nonsex specific cancer than women and more likely to die of the cancer even after controlling for the incidence. This discrepancy has been stable for the last decade. For 7 of the 10 most commonly occurring nonsex specific cancers, representing 78% of all incident cancers, men are more likely to be diagnosed with advanced stage.

KW - Humans

KW - Male

KW - Female

KW - Risk Factors

KW - Sex Distribution

KW - United States/epidemiology

KW - Neoplasms/mortality

KW - Humans

KW - Male

KW - Female

KW - Risk Factors

KW - Sex Distribution

KW - United States/epidemiology

KW - Neoplasms/mortality

U2 - 10.1016/j.juro.2012.11.153

DO - 10.1016/j.juro.2012.11.153

M3 - SCORING: Journal article

C2 - 23206422

VL - 189

SP - 1470

EP - 1474

JO - J UROLOGY

JF - J UROLOGY

SN - 0022-5347

IS - 4

M1 - 4

ER -